Dicerna Pharmaceuticals, Inc.

Novo Nordisk is a globally recognized healthcare company with headquarters in Denmark. Founded over a century ago, the company initially focused on diabetes care, but has expanded its expertise to include obesity, rare diseases, and cardiovascular conditions. Novo Nordisk boasts a strong commitment to research and development, constantly innovating to create biological medicines and delivery systems for patients worldwide. They treat millions of patients globally and are committed to making their medicines accessible and affordable through initiatives like the NovoCare Affordability Program.

Beyond its core business, Novo Nordisk demonstrates a commitment to social responsibility through its "Defeat Diabetes" strategy. This includes initiatives like Cities Changing Diabetes, which helps urban communities address diabetes challenges, and programs like NovoCare, which aids patients in accessing affordability support. They are also deeply committed to environmental sustainability, aiming for zero environmental impact across all operations and products. Novo Nordisk is driven by a patient-centered approach, reflected in its culture and dedication to improving the lives of people living with chronic diseases.

Novo Nordisk offers flexible work arrangements, including remote work options. The company emphasizes its commitment to providing employees with a healthy and engaging work environment, suggesting a focus on employee well-being and work-life balance.

Novo Nordisk offers a comprehensive benefits package to its employees, including medical, dental, and vision insurance, as well as life insurance, short- and long-term disability coverage, and a 401(k) retirement savings plan with a company match. Employees also enjoy paid time off, holidays, and sick leave, as well as access to employee resource groups and a variety of wellness programs.

Novo Nordisk is a global healthcare company dedicated to driving change to defeat serious chronic diseases. They focus on developing innovative biological medicines and making them accessible and affordable to patients worldwide. With a heritage rooted in diabetes care, they have expanded their reach to treat obesity, rare diseases, and cardiovascular conditions. Their mission is to improve the lives of patients by providing them with the tools and resources to manage their health and live longer, healthier lives.

Novo Nordisk fosters a culture built on patient-centricity, innovation, and a strong sense of social responsibility. They emphasize collaboration, both internally and with external partners, and prioritize diversity, equity, inclusion, and belonging across their workforce. The company values openness, accountability, and respect, evident in their commitment to transparency, ethical business practices, and creating a healthy and engaging working environment.

Novo Nordisk believes in the power of diversity, equity, inclusion, and belonging (DEI&B) to drive innovation and create a more equitable world. They are committed to fostering a workplace where everyone feels valued, respected, and empowered to contribute their unique perspectives. This commitment is reflected in their dedication to diverse representation in clinical trials, their Supplier Diversity Program, and their nine Employee Resource Groups. Novo Nordisk also actively supports organizations that work to improve health equity and eliminate health disparities.